Peter A. Calabresi

Affiliations: 
Neurology Johns Hopkins University, Baltimore, MD 
Area:
multiple sclerosis
Google:
"Peter Calabresi"
Mean distance: 15.65 (cluster 17)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Levit E, Ren Z, Gonzenbach V, et al. (2024) Choroid plexus volume differentiates MS from its mimics. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585241238094
Freedman MS, Gnanapavan S, Booth RA, et al. (2024) Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management. Ebiomedicine. 101: 104970
Ladakis DC, Harrison KL, Smith MD, et al. (2024) Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease. Medrxiv : the Preprint Server For Health Sciences
Bagnato F, Sati P, Hemond CC, et al. (2024) Imaging chronic active lesions in multiple sclerosis: a consensus statement. Brain : a Journal of Neurology
Daboul L, O'Donnell CM, Amin M, et al. (2023) A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231214360
Ladakis DC, Reyes-Mantilla MI, Gadani SP, et al. (2023) Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231213164
Thompson AJ, Moccia M, Amato MP, et al. (2023) Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231196786
Gadani SP, Calabresi PA. (2023) The calvaria stands alone: Unique aspects of the skull bone marrow-meninges border. Cell. 186: 3524-3526
Clark KA, O'Donnell CM, Elliott MA, et al. (2023) Intersite brain MRI volumetric biases persist even in a harmonized multisubject study of multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
Newsome SD, Tian F, Shoemaker T, et al. (2023) A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics
See more...